Markets & regulatory news

BI wins antibody contract

BI wins antibody contract

German biotechnology company TeGenero has signed up Boehringer
Ingelheim to make clinical trials of its antibody drug in a move
that reflects an emerging trend in the contract manufacturing
sector.

Tough times at CyBio

Tough times at CyBio

Germany's CyBio, which makes laboratory instruments and equipment,
has seen its revenues in the first nine months of the year fall by
a third and expects to post a full-year loss.

Organon looks East

Organon looks East

Dutch company Organon has upgraded its manufacturing facilities in
China in a move that will for the first time allow it to create
pharmaceuticals for local consumption.

Solid 3Q showing at Evotec

Solid 3Q showing at Evotec

Evotec OAI once again defied the difficult environment for drug
discovery technology companies with a 20 per cent hike in
nine-month revenues to €56.7 million. Growth was driven by the
firm's ultra high-throughput screening collaboration...

Expansion for Ultrafine

Expansion for Ultrafine

Ultrafine has started construction of an additional facility to
expand its capabilities in the custom manufacturing of active
pharmaceutical ingredients (APIs) and intermediates.

EU IPO rush to follow US?

EU IPO rush to follow US?

October has seen a rush by US biotechnology companies to list on
the stock markets, bringing to an end an Initial Public Offering
(IPO) drought lasting more than 18 months. Is Europe destined to
follow?

Off-the-peg LIMS

Off-the-peg LIMS

Sales of commercial Laboratory Information Management Systems
(LIMS) are set for strong growth as manufacturers turn away from
home-grown systems

New contracts for EPPS

New contracts for EPPS

EaglePicher Pharmaceutical Services (EPPS) of the USA says it has
received $1.8 million (€1.5m) in late-stage development contracts
for active pharmaceutical ingredients (API).

Sartorius/KMI go global

Sartorius/KMI go global

Sartorius North America and KMI/Parexel International have formed
an alliance that will improve the geographic reach of their
biopharmaceutical production and consultancy services.

Follow us

Webinars

Headlines